2025 Global Glycomics Glycobiology Market Top Companies
Author:
Intellectual Market Insights Research
Published Date:
27 Apr 2025
Top Companies in the Glycomics/Glycobiology Market (2024 Profiles)
Company | Headquarters | Founded | Employees | Revenue 2024 | |
Agilent Technologies, Inc. | California, USA | 1999 | 17,000+ | Approx. $7.5 Billion | |
Thermo Fisher Scientific Inc. | Massachusetts, USA | 1956 | 130,000+ | Approx. $43 Billion | |
Merck KGaA (MilliporeSigma in USA) | Darmstadt, Germany | 1668 | 64,500+ | Approx. $25 Billion | |
New England Biolabs | Massachusetts, USA | 1974 | Approx. 550 | Approx. $320 Million | |
Takara Bio Inc. | Shiga, Japan | 1967 | Approx. 1,600 | Approx. $400 Million | |
Waters Corporation | Massachusetts, USA | 1958 | 7,800+ | Approx. $2.9 Billion | |
Bruker Corporation | Massachusetts, USA | 1960 | 7,500+ | Approx. $2.8 Billion | |
Shimadzu Corporation | Kyoto, Japan | 1875 | 13,500+ | Approx. $4 Billion | |
Asparia Glycomics S.L. | San Sebastian, Spain | 2005 | Approx. 100 | Approx. $10 Million | |
RayBiotech, Inc. | Georgia, USA | 2001 | Approx. 150 | Approx. $30 Million |
Key Trends Driving the Market
- Rise of Personalized Medicine: Glycomics enables biomarker discovery for individualized therapies.
- Vaccine Innovation: Understanding glycan interactions accelerates novel vaccine development (e.g., COVID-19, cancer vaccines).
- High-Throughput Glycan Analysis: Automation and miniaturization of glycan profiling assays.
- Oncology Research: Glycans as therapeutic targets in immuno-oncology.
- Strategic Collaborations: Universities, research centers, and industry players are forming strong partnerships for innovation.
Regional Market Analysis (2025 Outlook)
Region | Growth Highlights | Drivers |
North America | Largest market share | Biotech R&D investment, cancer research, major pharma hubs (USA, Canada) |
Europe | Robust expansion | Government funding in genomics and bioinformatics (Germany, UK, France) |
Asia-Pacific | Fastest-growing | Rising healthcare infrastructure, aging population, booming pharma sectors (China, India, Japan) |
Middle East and Africa | Emerging market | Strategic partnerships, healthcare modernization (UAE, South Africa) |
South America | Steady growth | Government initiatives and expanding pharmaceutical industry (Brazil, Argentina) |
Conclusion: The Sugar Revolution
Glycomics and glycobiology are rapidly moving from a niche research area to a central pillar of biotechnology innovation. With breakthroughs in bioinformatics, advanced analytical tools, and an increasing demand for precision medicine, the glycomics/glycobiology industry is set for explosive growth through 2032.
Leading companies that invest early in R&D, strategic collaborations, and regional expansion will be best positioned to capitalize on the market boom.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
About US:
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
